While numerous real estate investment trusts face pressure from interest rate concerns, Universal Health Realty Income Trust has demonstrated surprising...

Significant stock sales by Palantir Technologies Inc.'s top executives are delivering a concerning message to the market. The very managers...

What separates a promising biotech company from a true market leader? Halozyme Therapeutics is providing a compelling case study with...

Cinemark Holdings finds itself at a financial crossroads, balancing strategic credit enhancements against a backdrop of quarterly results that fell...

Celcuity Inc. saw its stock price climb to an unprecedented peak of $55.58 on Friday, cementing a remarkable year-to-date gain...

Alphabet investors experienced a dramatic trading session on Friday as conflicting regulatory developments created significant market volatility. While a U.S....

Shares of Viking Therapeutics experienced a dramatic sell-off after the biopharmaceutical company released Phase 2 trial results for its oral...

Market experts continue to endorse N-Able shares with a "Moderate Buy" consensus recommendation, even as the company's Executive Vice President...

TG Therapeutics is demonstrating extraordinary momentum, largely driven by the remarkable performance of its flagship therapy. While numerous pharmaceutical companies...

Regional U.S. lender OceanFind Financial Corp. is presenting investors with a complex narrative. The institution's leadership has initiated a substantial...